ScholarLens Back to search
2022•International Journal of Clinical PharmacyRequires access

The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population

Hock Peng Koh, Adyani Md Redzuan, Shamin Mohd Saffian, Jivanraj R. Nagarajah, Noel Thomas Ross, Hasnita Hassan

Open publisher page 8 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tenecteplase, Streptokinase, Medicine, Thrombolysis, Myocardial infarction, Propensity score matching, Fibrinolytic agent, Population

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population — Research Paper | ScholarLens